Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MRND IQ U.S. Mid Cap R&D Leaders ETF (MRND) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock Analysis About IQ U.S. Mid Cap R&D Leaders ETF (NASDAQ:MRND) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get MRND alerts:Sign Up Key Stats Today's Range$23.57▼$23.5750-Day Range$20.74▼$23.5752-Week Range$19.08▼$23.84Volume10 shsAverage Volume157 shsMarket Capitalization$4.71 millionAssets Under Management$4.71 millionDividend Yield0.72%Net Expense Ratio0.16%Aggregate RatingModerate Buy ETF OverviewThe IQ U.S. Mid Cap R&D Leaders ETF (MRND) is an exchange-traded fund that is based on the IQ U.S. Mid Cap R&D Leaders index. The fund tracks an index of 100 mid-cap US companies selected and weighted based on the most recently reported one year research and development (R&D) spending. MRND was launched on Feb 8, 2022 and is managed by IndexIQ.Read More… IQ U.S. Mid Cap R&D Leaders ETF ExpensesTypeMRNDMid Cap ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.16%0.34%0.55%0.50%0.52%Other Expenses0.01%0.47%0.49%0.41%0.53%Total Expense0.17%0.49%0.71%0.64%0.71%Fee Waiver-0.01%-0.68%-0.51%-0.31%-0.56%Net Expense0.16%0.37%0.61%0.57%0.59% Receive MRND Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IQ U.S. Mid Cap R&D Leaders ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address MRND ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Fund Details IssuerIndexIQ Fund NameIQ U.S. Mid Cap R&D Leaders ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:MRND Inception Date2/8/2022 Fund ManagerGreg Barrato, James Harrison WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIQ U.S. Mid Cap R&D Leaders Index CategorySize and Style FocusMid Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings101 Fund Statistics Assets Under Management$4.71 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorIndexIQ Advisors LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares200,000Beta1.09 Creation Fee$250.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Top 10 MRND HoldingsRivian Automotive (NASDAQ:RIVN)Holding Weight: 4.20%Block (NYSE:SQ)Holding Weight: 3.42%Electronic Arts (NASDAQ:EA)Holding Weight: 3.23%Dell Technologies (NYSE:DELL)Holding Weight: 2.58%Biogen (NASDAQ:BIIB)Holding Weight: 2.29%Incyte (NASDAQ:INCY)Holding Weight: 2.10%eBay (NASDAQ:EBAY)Holding Weight: 1.93%Spotify Technology (NYSE:SPOT)Holding Weight: 1.93%Hewlett Packard Enterprise (NYSE:HPE)Holding Weight: 1.92%Cummins (NYSE:CMI)Holding Weight: 1.87%Full Holdings Details This page (NASDAQ:MRND) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQ U.S. Mid Cap R&D Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share IQ U.S. Mid Cap R&D Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.